Modification of alterations in cardiac function and sarcoplasmic reticulum by vanadate in ischemic-reperfused rat hearts

Journal of Applied Physiology

Volumn 99, Issue 3, 2005, Pages 999-1005

  Takeda, Satoshi ^c   Mochizuki, Seibu ^c   Saini, Harjot K ^a,b   Elimban, Vijayan ^a,b   Dhalla, Naranjan S ^a,b  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Ischemia reperfusion; Oxidative stress

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ANTIOXIDANT; CALCIUM ION; CATALASE; HYDROGEN PEROXIDE; OXYGEN RADICAL; SUPEROXIDE DISMUTASE; VANADIC ACID; XANTHINE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART PERFORMANCE; HEART PROTECTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE PRESSURE; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; REPERFUSION INJURY; SARCOPLASMIC RETICULUM;

ANIMALS; ANTIOXIDANTS; CALCIUM; CALCIUM SIGNALING; HEART VENTRICLES; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SARCOPLASMIC RETICULUM; TREATMENT OUTCOME; VANADATES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 24044490912     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00234.2005     Document Type: Article

References (36)

1. Babick AP, Cantor EJ, Babick JT, Takeda N, Dhalla NS, and Netticadan T. Cardiac contractile dysfunction in J2N-k cardiomyopathic hamsters is associated with impaired SR function and regulation. Am J Physiol Cell Physiol 287: C1202-C1208, 2004.
2. Bers DM. Sarcoplasmic reticulum calcium release in intact ventricular myocytes. Front Biosci 7: d1697-d1711, 2002.
3. Bolli R and Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 79: 609-634, 1999.
4. Brunner F, Leonhard B, Kukovetz WR, and Mayer B. Role of endothelin, nitric oxide and L-arginine release in ischemia/reperfusion injury of rat heart. Cardiovasc Res 36: 60-66, 1997.
5. Chernoff J and Li HC. A major phosphotyrosyl-protein phosphatase from bovine heart is associated with a low-molecular-weight acid phosphatase. Arch Biochem Biophys 240: 135-145, 1985.
6. Dhalla NS, Elmoselhi AB, Hata T, and Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 47: 446-456, 2000.
7. Dhalla NS, Liu X, Panagia V, and Takeda N. Subcellular remodeling and heart dysfunction in chronic diabetes. Cardiovasc Res 40: 239-247, 1998.
8. Ding M, Li JJ, Leonard SS, Ye JP, Shi X, Colburn NH, Castranova V, and Vallyathan V. Vanadate-induced activation of activator protein-1: role of reactive oxygen species. Carcinogenesis 20: 663-668, 1999.
9. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002.
10. Duckworth WC, Solomon SS, Liepnieks J, Hamel FG, Hand S, and Peavy DE. Insulin-like effects of vanadate in isolated rat adipocytes. Endocrinology 122: 2285-2289, 1988.
11. Fabiato A. Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Physiol Cell Physiol 245: C1-C14, 1983.
12. Heyliger CE, Tahiliani AG, and McNeill JH. Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 227: 1474-1477, 1985.
13. Kalyani P, Vijaya S, and Ramasarma T. Characterization of oxygen free radicals generated during vanadate-stimulated NADH oxidation. Mol Cell Biochem 111: 33-40, 1992.
14. Loh SH, Jin JS, Tsai CS, Chao CM, Tsai Y, Chen WH, Cheng TH, Chuang CC, and Lin CI. Possible underlying mechanism for hydrogen peroxide-induced electromechanical suppression in human atrial myocardium. J Pharm Sci 91: 53-60, 2003.
15. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ. Protein measurement with the Polin phenol reagent. J Biol Chem 193: 265-275, 1951.
16. Mackay K and Mochly-Rosen D. Involvement of a p38 mitogen-activated protein kinase phosphatase in protecting neonatal rat cardiac myocytes from ischemia. J Mol Cell Cardiol 32: 1585-1588, 2000.
17. Matsubara T, Musat-Marcu S, Misra HP, and Dhalla NS. Protective effect of vanadate on oxyradical-induced changes in isolated perfused heart. Mol Cell Biochem 153: 79-85, 1995.
18. Maulik N, Liu X, Subramanian R, and Das DK. Release of endothelin during reperfusion of ischemic myocardium. ET-1 release from reperfused heart. Am J Cardiovasc Pathol 4: 133-144, 1992.
19. Molavi B and Mehta JL. Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations. Curr Opin Cardiol 19: 488-493, 2004.
20. Noda C, Masuda T, Sato K, Ikeda K, Shimohama T, Matsuyama N, and Izumi T. Vanadate improves cardiac function and myocardial energy metabolism in diabetic rat hearts. Jpn Heart J 44: 745-757, 2003.
21. Osada M, Netticadan T, Tamura K, and Dhalla NS. Modification of ischemia-reperfusion-induced changes in cardiac sarcoplasmic reticulum by preconditioning. Am J Physiol Heart Circ Physiol 274: H2025-H2034, 1998.
22. Ramanadham S, Mongold JJ, Brownsey RW, Cros GH, and McNeill JH. Oral vanadyl sulfate in treatment of diabetes mellitus in rats. Am J Physiol Heart Circ Physiol 257: H904-H911, 1989.
23. Saini HK and Dhalla NS. Defective calcium handling in cardiomyocytes isolated from hearts subjected to ischemia-reperfusion. Am J Physiol Heart Circ Physiol 288: H2260-H2270, 2005.
24. Sato M, Ray PS, Maulik G, Maulik N, Engelman RM, Bertelli AA, Bertelli A, and Das DK. Myocardial protection with red wine extract. J Cardiovasc Pharmacol 35: 263-268, 2000.
25. Sekar N, Kanthasamy A, William S, Balasubramaniyan N, and Govindasamy S. Antioxidant effect of vanadate on experimental diabetic rats. Acta Diabetol 27: 285-293, 1990.
26. Shah KR, Matsubara T, Foerster DR, Xu YJ, and Dhalla NS. Mechanisms of inotropic responses of the isolated rat hearts to vanadate. Int J Cardiol 52: 101-113, 1995.
27. Shechter Y and Karlish SJ. Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl (IV) ions. Nature 284: 556-558, 1980.
28. Singh RB, Chohan PK, Dhalla NS, and Netticadan T. The sarcoplasmic reticulum proteins are targets for calpain action in the ischemic-reperfused heart. J Mol Cell Cardiol 37: 101-110, 2004.
29. Takeda S, Prajapati D, Mochizuki S, Elimban V, and Dhalla NS. Attenuation of ischemia-reperfusion induced changes in cardiac performance and sarcoplasmic reticulum function by vanadate. Exp Clin Cardiol 8: 134-138, 2003.
30. Takeda Y, Hashimoto M, Kasahara J, Aihara K, and Fukunaga K. Cytoprotective effect of sodium orthovanadate on ischemia/reperfusion-induced injury in the rat heart involves Akt activation and inhibition of fodrin breakdown and apoptosis. J Pharmacol Exp Ther 311: 1249-1255, 2004.
31. Temsah RM, Kawabata K, Chapman D, and Dhalla NS. Preconditioning prevents alterations in cardiac SR gene expression due to ischemia-reperfusion. Am J Physiol Heart Circ Physiol 282: H1461-H1466, 2002.
32. Temsah RM, Netticadan T, Chapman D, Takeda S, Mochizuki S, and Dhalla NS. Alterations in sarcoplasmic reticulum function and gene expression in ischemic-reperfused rat heart. Am J Physiol Heart Circ Physiol 277: H584-H594, 1999.
33. Tolman EL, Barris E, Burns M, Pansini A, and Partridge R. Effects of vanadium on glucose metabolism in vitro. Life Sci 25: 1159-1164, 1979.
34. Tracey AS and Gresser MJ. Interaction of vanadate with phenol and tyrosine: implications for the effects of vanadate on systems regulated by tyrosine phosphorylation. Proc Natl Acad Sci USA 83: 609-613, 1986.
35. 2-induced apoptosis via MAP kinase-MKP-1 pathway. Free Radic Biol Med 36: 985-993, 2004.
36. Yin X, Davison AJ, and Tsang SS. Vanadate-induced gene expression in mouse C127 cells: roles of oxygen-derived active species. Mol Cell Biochem 115: 85-96, 1992.